Open company graph database — free web & API
Login

Daichiku Corporation

株式会社ダイチク
Ticker
—
Listed market
—
Country
Japan
Employees (non-consolidated)
—
Related companies
8
§01

Basic information

BASIC
Head office
Chief executive
Capital
Employees (non-consolidated)
Employees (consolidated)
Start date
End date
§02

Websites

1 DOMAINS
§03

Business

1
Dispensing Pharmacy Business
§04

Related companies

8 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
AinPharmacies Inc.
Group
Ain Central Corporation
Group
Ain Shinshu Co., Ltd.
Group
Francfranc Co., Ltd.
Group
アイングループ
Group
アイングループ調剤薬局事業会社
Group
株式会社エーアンドエム
Group
Pharmacy Inc.
Group
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

19 EVENTS

Established in 1969 as a company handling contracted clinical testing.Sources

In 1980, the Company launched its drug store business, the predecessor of its current business, and went public 14 years later.Sources

Established Dispensing Pharmacy Business Division.Sources

Established WHOLESALE STARS Co., Ltd. and started generic pharmaceutical wholesales.Sources

In January 2007, Daichiku Corporation (now Ain Hokuriku Corporation) was made a subsidiary.Sources

In June 2008, Daichiku Corporation was fully owned through share exchange with AIN Medical Systems Corporation (now AIN Pharamacies Corporation).Sources

In April 2009, listed on the Tokyo Stock Exchange Second Section.Sources

In June 2009, jointly established with Seven & I Holdings Co., Ltd., Ito-Yokado Co., Ltd., and 7-Eleven Japan Co., Ltd., a drugstore operating company "Seven Healthcare Corporation."Sources

In April 2010, designated on the First Section of the Tokyo Stock Exchange.Sources

In May 2010, listed on the Sapporo Securities Exchange.Sources

In November 2013, relocated the head office to Shiroishi-ku, Sapporo.Sources

In September 2015, acquired Ayura Laboratories Corporation.Sources

In November 2015, changed the company name to AIN Holdings Co., Ltd. and transferred rights and obligations related to business divisions to the consolidated subsidiary AIN Pharamacies Co., Ltd. as part of the transition to a holding company structure.Sources

In October 2017, conducted a public offering and third-party allotment, resulting in capital of 21.8497 billion yen.Sources

In March 2020, signed a business alliance agreement with Shidax Corporation and made its subsidiary Shidax AI Corporation (now AIN Pharamacies) a subsidiary.Sources

In April 2022, transitioned from the First Section to the Prime Market due to a review of market segments by the Tokyo Stock Exchange.Sources

In May 2022, acquired Pharmax Holdings Co., Ltd. (now Pharmax Co., Ltd.) as a subsidiary.Sources

In August 2024, acquired Francfranc Co., Ltd. as a subsidiary.Sources

In April 2025, acquired A&M Co., Ltd. as a subsidiary.Sources

§07

News

0 ARTICLES

There is no news.

§09

Sources & updates

SOURCES
↑